ACC Schedule 2015: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(47 intermediate revisions by the same user not shown)
Line 1: Line 1:
Here is the page we will use to coordinate the TV events at AHA 2014. Open time slots are indicated below in red.
Here is the page we will use to coordinate the TV events at ACC 2015. Open time slots are indicated below in red.
 
Filming Location: Hyatt Regency McCormick Place, 2233 S. Martin Luther King Drive, Chicago, IL 60616


Filming Location: Manchester Grand Hyatt, 1 Market St, San Diego, CA 92101
   
----
----
__NOTOC__
__NOTOC__
Line 15: Line 15:


[[{{PAGENAME}}#Tuesday, March 17, 2015| Tuesday, March 17, 2015]]
[[{{PAGENAME}}#Tuesday, March 17, 2015| Tuesday, March 17, 2015]]
[[{{PAGENAME}}#Wednesday, March 18, 2015| Wednesday, March 18, 2015]]


----
----
Line 59: Line 57:


===2:00 PM===
===2:00 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Nicolai Tegn
*'''Topic:''' After Eight Study
*'''Embargo Lift:''' Monday March 16, 2015 at 11:45AM


===2:30 PM===
===2:30 PM===
Line 76: Line 76:
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>


== Sunday, November 16, 2014==
== Sunday, March 15, 2015==


===8:00 AM===
===8:00 AM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>


===8:45 AM===
===8:30 AM===
''8:45 AM - 9:00 AM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Stefanie Schulz
*'''Topic:''' Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)
*'''Embargo Lift:''' Sunday, November 16, 2014 at 3:55 PM


===9:00 AM===
===9:00 AM===
''9:00 AM - 9:30 AM''
*'''Interviewee:''' Dr. Philippe Généreux
*'''Interviewee:''' Dr. Kirk N. Garratt 
*'''Topic:''' ACC 2015 Wrap-Up in French
*'''Topic:''' Increased Risk of Ischemic Events Upon Discontinuation of Prasugrel After 12 or 30 Months of Therapy Following Placement of the Taxus Liberté Paclitaxel- Eluting Coronary Stent     
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:05 PM       


===9:30 AM===
===9:30 AM===
''9:30 AM - 10:00 AM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Martine Gilard
*'''Topic:''' Is 6 Months DAPT Post Coronary Stenting Non Inferior To 24 Months? The Italic/ Italic+ Randomized Trial. Results of the One Year Primary Endpoint
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:05 PM       


===10:00 AM===
===10:00 AM===
Line 106: Line 98:


===11:00 AM===
===11:00 AM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Luigi Di Biase
 
*'''Topic:''' Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted device: Results from the AATAC Multicenter Randomized Trial
===2:30 PM===
*'''Embargo Lift:''' Monday March 16, 2015 at 8:00AM
<font color=red>OPEN TIME SLOT</font>
 
===3:00 PM===
<font color=red>OPEN TIME SLOT</font>
 
===3:30 PM===
<font color=red>OPEN TIME SLOT</font>
 
===4:00 PM===
<font color=red>OPEN TIME SLOT</font>
 
===4:30 PM===
<font color=red>OPEN TIME SLOT</font>
 
==Monday, November 17, 2014==
 
===8:00 AM===
''8:00 AM - 8:30 AM''
*'''Interviewee:''' Dr. Christopher Granger and Dr. James Jollis     
*'''Topic:''' Developing Regional STEMI Systems of Care: Final Results of the Mission: Lifeline STEMI ACCELERATOR Study         
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 11:41 AM       
 
===8:30 AM===
''8:30 AM - 9:00 AM''
*'''Interviewee:''' Dr. Christoph Kaiser
*'''Topic:''' Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-eluting Stents and Bare Metal Stents - Main Results of a Prospective Randomized Trial     
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 10:45 AM     
 
===9:00 AM===
''9:00 AM - 9:15 AM''
*'''Interviewee:''' Dr. Patrick Moriarty     
*'''Topic:''' ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm     
*'''Embargo Lift:''' Monday, November 17, 2014 at 11:29 AM     
 
===9:15 AM===
''9:15 AM - 9:30 AM''
*'''Interviewee:''' Dr. Robert Giugliano
*'''Topic:''' IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes
*'''Embargo Lift:''' Monday, November 17, 2014 at 11:51 AM
 
===9:30 AM===
''9:30 AM - 10:00 AM''
*'''Interviewee:''' Dr. Renato Lopes       
*'''Topic:''' AHA 2014 Wrap-Up in Portuguese
 
===10:00 AM===
<font color=red>OPEN TIME SLOT</font
 
===10:30 AM===
<font color=red>OPEN TIME SLOT</font>
 
===11:00 AM===
<font color=red>OPEN TIME SLOT</font>


===11:30 AM===
===11:30 AM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Derek J. Hausenloy
*'''Topic:''' Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Multi-Center Randomized Controlled Clinical Trial
*'''Embargo Lift:''' Monday March 16, 2015 at 9:00AM


===12:00 PM===
===12:00 PM===
Line 173: Line 114:


===1:00 PM===
===1:00 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Giora Weisz
*'''Topic:''' ACC 2015 "Impact of the PEGASUS Trial on Clinical Practice"


===1:30 PM===
===1:30 PM===
''1:30 PM - 2:00 PM''
*'''Interviewee:''' Dr. Michael J. Mack
*'''Interviewee:''' Dr. Philip Aylward
*'''Topic:''' Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of the PARTNER 1 Trial
*'''Topic:''' AHA 2014 Wrap-Up from a Pacific Rim perspective     
*'''Embargo Lift:''' Sunday March 15, 2015 at 10:45AM


===2:00 PM===
===2:00 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Paul Sorajja
*'''Topic:''' Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the United States
*'''Embargo Lift:''' Sunday March 15, 2015 at 11:45AM


===2:30 PM===
===2:30 PM===
''2:30 PM - 3:00 PM''
*'''Interviewee:''' Dr. David E. Newby
*'''Interviewee:''' Dr. Paul Armstrong, Dr. Justin Ezekowitz, Dr. Robert Welsh and Dr. Shaun Goodman     
*'''Topic:''' Computed Tomography Coronary Angiography In Patients With Suspected Angina Due To Coronary Heart Disease
*'''Topic:''' AHA 2014 Wrap-Up from a Canadian perspective     
*'''Embargo Lift:''' Sunday March 15, 2015 at 8:45AM


===3:00 PM===
===3:00 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Freek W. A. Verheugt
*'''Topic:''' ACC 2015 Wrap-Up from perspective of the Netherlands


===3:30 PM===
===3:30 PM===
''3:30 PM - 4:00 PM''
*'''Interviewee:''' Dr. Alexandra J. Lansky
*'''Interviewee:''' Dr. Samuel Wright
*'''Topic:''' First Report of the DEFLECT III Trial Results: A Prospective Randomized Evaluation of The TriGuardTM HDH Embolic DEFLECTion Device During Transcatheter Aortic Valve Replacement   
*'''Topic:''' CSL112 Posters: “CSL112 Enhances Cholesterol Efflux Equally in Patients with high and Low HDL Functionality” and “Mechanism of HDL remodeling induced by CSL112”)
*'''Embargo Lift:''' Sunday March 15, 2015 at 11:30AM
*'''Embargo Lift:''' Tuesday, November 18, 2014


===4:00 PM===
===4:00 PM===
''4:00 PM - 4:15 PM''
*'''Interviewee:''' Dr. Basil Lewis
*'''Interviewee:''' Dr. Basil Lewis        
*'''Topic:''' ACC 2015 Wrap-Up in Hebrew
*'''Topic:''' AHA 2014 Wrap-Up in Hebrew


===4:15 PM===
===4:30 PM===
''4:15 PM - 4:45 PM''
*'''Interviewee:''' Dr. Michael J. Reardon
*'''Interviewee:''' Dr. Kazuyuki Shimada     
*'''Topic:''' A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes
*'''Topic:''' Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Patients With Multiple Atherosclerotic Risk Factors: A Randomized Controlled Trial     
*'''Embargo Lift:''' Sunday March 15, 2015 at 11:00AM
*'''Embargo Lift:''' Monday, November 17, 2014 at 10:45 AM


===5:00 PM===
===5:00 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Seung-Jung Park
 
*'''Topic:''' Everolimus-Eluting Stents versus Bypass Surgery for Multivessel Coronary Artery Disease
===5:30 PM===
*'''Embargo Lift:''' Monday March 16, 2015 at 8:45AM
''5:30 PM - 6:00 PM''
*'''Interviewee:''' Dr. Gilles Montalescot       
*'''Topic:''' AHA 2014 Wrap-Up in French
 
==Tuesday, November 18, 2014==


===7:30 AM===
==Monday, March 16, 2015==
''7:30 AM - 8:00 AM''
*'''Interviewee:''' Dr. Robert Michler       
*'''Topic:''' The Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:51 AM


===8:00 AM===
===8:00 AM===
Line 228: Line 161:


===8:30 AM===
===8:30 AM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Renato Lopes
*'''Topic:''' ACC 2015 Wrap-Up in Portuguese


===9:00 AM===
===9:00 AM===
''9:00 AM - 9:30 AM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Dean Kereiakes       
*'''Topic:''' Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 10:55 AM


===9:30 AM===
===9:30 AM===
Line 240: Line 171:


===10:00 AM===
===10:00 AM===
''10:00 AM - 10:30 AM''
*'''Interviewee:''' Dr. Philip A. Aylward
*'''Interviewee:''' Dr. Dion Stub         
*'''Topic:''' ACC 2015 Wrap-Up from perspective of the Pacific Rim
*'''Topic:''' A Randomised Controlled Trial of Oxygen Therapy in Acute St-segment Elevation Myocardial Infarction: The Air Versus Oxygen in Myocardial Infarction (AVOID) Study           
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 11:19 AM     


===10:30 AM===
===10:30 AM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Daniel B. Mark
*'''Topic:''' Economic Comparison of Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected CAD: Results from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) Trial
*'''Embargo Lift:''' Sunday March 15, 2015 at 9:00AM


===11:00 AM===
===11:00 AM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Marc Gillinov
*'''Topic:''' Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network   
*'''Embargo Lift:''' Monday March 16, 2015 at 8:15AM


===11:30 AM===
===11:30 AM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Rajeev K. Pathak
*'''Topic:''' Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study)
*'''Embargo Lift:''' Monday March 16, 2015 at 8:30AM


===12:00 PM===
===12:00 PM===
''12:00 PM - 12:30 PM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Hisao Ogawa         
*'''Topic:''' AHA 2014 Wrap-Up in Japanese


===12:30 PM===
===12:30 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Rino Sardella
*'''Topic:''' ACC 2015 Wrap-Up in Italian


===1:00 PM===
===1:00 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Hisao Ogawa
*'''Topic:''' ACC 2015 Wrap-Up in Japanese


===1:30 PM===
===1:30 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Susheel Kodali
*'''Topic:''' Early Clinical and Echocardiographic Outcomes with the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-Risk and Intermediate-Risk Aortic Stenosis Patients   
*'''Embargo Lift:''' Sunday March 15, 2015 at 11:15AM


===2:00 PM===
===2:00 PM===
''2:00 PM - 2:30 PM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Stefan James       
*'''Topic:''' AHA 2014 Wrap-Up from a Scandinavian perspective


===2:30 PM===
===2:30 PM===
''2:30 PM - 3:00 PM''
*'''Interviewee:''' Dr. Pamela S. Douglas
*'''Interviewee:''' Dr. Mark Dayer
*'''Topic:''' A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain)
*'''Topic:''' The Incidence of Infective Endocarditis in England is Increasing - An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics
*'''Embargo Lift:''' Saturday March 14, 2015 at 9:05AM
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:29 AM 


===3:00 PM===
===3:00 PM===
''3:00 PM - 3:30 PM''
*'''Interviewee:''' Dr. Marco Valgimigli
*'''Interviewee:''' Dr. Freek W.A. Verheugt         
*'''Topic:''' Transradial Versus Transfemoral Access In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Access Site Program '''&''' Bivalirudin Infusion Compared To Unfractionated Heparin In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program
*'''Topic:''' AHA 2014 Wrap-Up from a Netherlands perspective
*'''Embargo Lift:''' Monday March 16, 2015 at 11:00AM '''&''' Monday March 16, 2015 at 11:15AM, respectively


===3:30 PM===
===3:30 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Marc Steven Sabatine     
*'''Topic:''' Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes     
*'''Embargo Lift:''' Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively     


===4:00 PM===
===4:00 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Roxana Mehran
*'''Topic:''' A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention
*'''Embargo Lift:''' Sunday March 15, 2015 at 8:30AM


===4:30 PM===
===4:30 PM===
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Thomas Engstrøm
*'''Topic:''' The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease
*'''Embargo Lift:''' Monday March 16, 2015 at 11:30AM
 
===5:00 PM===
*'''Interviewee:''' Prof. Dr. Sigmund Silber
*'''Topic:''' ACC 2015 Wrap-Up in German


==Wednesday, November 19, 2014==
==Tuesday, March 17, 2015==


===8:00 AM===
===8:00 AM===
Line 308: Line 252:


===10:00 AM===
===10:00 AM===
''10:00 AM - 10:30 AM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Anna Axelsson     
*'''Topic:''' A Randomized Trial of Losartan In Hypertrophic Cardiomyopathy - The INHERIT Trial
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:07 AM     


===10:30 AM===
===10:30 AM===
''10:30 AM - 11:00 AM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Laura Mauri
*'''Topic:''' Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study     
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:15 PM     


===11:00 AM===
===11:00 AM===
''11:00 AM - 11:30 AM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Westby Fisher   
*'''Topic:''' ABIM Maintenance of Certification program     


===11:30 AM===
===11:30 AM===
Line 349: Line 285:


===3:30 PM===
===3:30 PM===
''3:30 PM - 4:00 PM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Prof. Dr. Sigmund Silber   
*'''Topic:''' AHA 2014 Wrap-Up in German


===4:00 PM===
===4:00 PM===

Latest revision as of 15:20, 11 March 2015

Here is the page we will use to coordinate the TV events at ACC 2015. Open time slots are indicated below in red.

Filming Location: Manchester Grand Hyatt, 1 Market St, San Diego, CA 92101


Click on Date for Detailed Schedule

Saturday, March 14, 2015

Sunday, March 15, 2015

Monday, March 16, 2015

Tuesday, March 17, 2015

Saturday, March 14, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

OPEN TIME SLOT

9:30 AM

OPEN TIME SLOT

10:00 AM

OPEN TIME SLOT

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

11:30 AM

OPEN TIME SLOT

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

OPEN TIME SLOT

2:00 PM

  • Interviewee: Dr. Nicolai Tegn
  • Topic: After Eight Study
  • Embargo Lift: Monday March 16, 2015 at 11:45AM

2:30 PM

OPEN TIME SLOT

3:00 PM

OPEN TIME SLOT

3:30 PM

OPEN TIME SLOT

4:00 PM

OPEN TIME SLOT

4:30 PM

OPEN TIME SLOT

Sunday, March 15, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

  • Interviewee: Dr. Philippe Généreux
  • Topic: ACC 2015 Wrap-Up in French

9:30 AM

OPEN TIME SLOT

10:00 AM

OPEN TIME SLOT

10:30 AM

OPEN TIME SLOT

11:00 AM

  • Interviewee: Dr. Luigi Di Biase
  • Topic: Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted device: Results from the AATAC Multicenter Randomized Trial
  • Embargo Lift: Monday March 16, 2015 at 8:00AM

11:30 AM

  • Interviewee: Dr. Derek J. Hausenloy
  • Topic: Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Multi-Center Randomized Controlled Clinical Trial
  • Embargo Lift: Monday March 16, 2015 at 9:00AM

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

  • Interviewee: Dr. Giora Weisz
  • Topic: ACC 2015 "Impact of the PEGASUS Trial on Clinical Practice"

1:30 PM

  • Interviewee: Dr. Michael J. Mack
  • Topic: Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of the PARTNER 1 Trial
  • Embargo Lift: Sunday March 15, 2015 at 10:45AM

2:00 PM

  • Interviewee: Dr. Paul Sorajja
  • Topic: Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the United States
  • Embargo Lift: Sunday March 15, 2015 at 11:45AM

2:30 PM

  • Interviewee: Dr. David E. Newby
  • Topic: Computed Tomography Coronary Angiography In Patients With Suspected Angina Due To Coronary Heart Disease
  • Embargo Lift: Sunday March 15, 2015 at 8:45AM

3:00 PM

  • Interviewee: Dr. Freek W. A. Verheugt
  • Topic: ACC 2015 Wrap-Up from perspective of the Netherlands

3:30 PM

  • Interviewee: Dr. Alexandra J. Lansky
  • Topic: First Report of the DEFLECT III Trial Results: A Prospective Randomized Evaluation of The TriGuardTM HDH Embolic DEFLECTion Device During Transcatheter Aortic Valve Replacement
  • Embargo Lift: Sunday March 15, 2015 at 11:30AM

4:00 PM

  • Interviewee: Dr. Basil Lewis
  • Topic: ACC 2015 Wrap-Up in Hebrew

4:30 PM

  • Interviewee: Dr. Michael J. Reardon
  • Topic: A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes
  • Embargo Lift: Sunday March 15, 2015 at 11:00AM

5:00 PM

  • Interviewee: Dr. Seung-Jung Park
  • Topic: Everolimus-Eluting Stents versus Bypass Surgery for Multivessel Coronary Artery Disease
  • Embargo Lift: Monday March 16, 2015 at 8:45AM

Monday, March 16, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

  • Interviewee: Dr. Renato Lopes
  • Topic: ACC 2015 Wrap-Up in Portuguese

9:00 AM

OPEN TIME SLOT

9:30 AM

OPEN TIME SLOT

10:00 AM

  • Interviewee: Dr. Philip A. Aylward
  • Topic: ACC 2015 Wrap-Up from perspective of the Pacific Rim

10:30 AM

  • Interviewee: Dr. Daniel B. Mark
  • Topic: Economic Comparison of Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected CAD: Results from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) Trial
  • Embargo Lift: Sunday March 15, 2015 at 9:00AM

11:00 AM

  • Interviewee: Dr. Marc Gillinov
  • Topic: Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network
  • Embargo Lift: Monday March 16, 2015 at 8:15AM

11:30 AM

  • Interviewee: Dr. Rajeev K. Pathak
  • Topic: Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study)
  • Embargo Lift: Monday March 16, 2015 at 8:30AM

12:00 PM

OPEN TIME SLOT

12:30 PM

  • Interviewee: Dr. Rino Sardella
  • Topic: ACC 2015 Wrap-Up in Italian

1:00 PM

  • Interviewee: Dr. Hisao Ogawa
  • Topic: ACC 2015 Wrap-Up in Japanese

1:30 PM

  • Interviewee: Dr. Susheel Kodali
  • Topic: Early Clinical and Echocardiographic Outcomes with the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-Risk and Intermediate-Risk Aortic Stenosis Patients
  • Embargo Lift: Sunday March 15, 2015 at 11:15AM

2:00 PM

OPEN TIME SLOT

2:30 PM

  • Interviewee: Dr. Pamela S. Douglas
  • Topic: A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain)
  • Embargo Lift: Saturday March 14, 2015 at 9:05AM

3:00 PM

  • Interviewee: Dr. Marco Valgimigli
  • Topic: Transradial Versus Transfemoral Access In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Access Site Program & Bivalirudin Infusion Compared To Unfractionated Heparin In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program
  • Embargo Lift: Monday March 16, 2015 at 11:00AM & Monday March 16, 2015 at 11:15AM, respectively

3:30 PM

  • Interviewee: Dr. Marc Steven Sabatine
  • Topic: Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes
  • Embargo Lift: Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively

4:00 PM

  • Interviewee: Dr. Roxana Mehran
  • Topic: A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention
  • Embargo Lift: Sunday March 15, 2015 at 8:30AM

4:30 PM

  • Interviewee: Dr. Thomas Engstrøm
  • Topic: The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease
  • Embargo Lift: Monday March 16, 2015 at 11:30AM

5:00 PM

  • Interviewee: Prof. Dr. Sigmund Silber
  • Topic: ACC 2015 Wrap-Up in German

Tuesday, March 17, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

OPEN TIME SLOT

9:30 AM

OPEN TIME SLOT

10:00 AM

OPEN TIME SLOT

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

11:30 AM

OPEN TIME SLOT

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

OPEN TIME SLOT

2:00 PM

OPEN TIME SLOT

2:30 PM

OPEN TIME SLOT

3:00 PM

OPEN TIME SLOT

3:30 PM

OPEN TIME SLOT

4:00 PM

OPEN TIME SLOT

4:30 PM

OPEN TIME SLOT

Retrieved from "https://www.wikidoc.org/index.php?title=ACC_Schedule_2015&oldid=1077227"